Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00423358 · ClinicalTrials.gov registry record · NA

Treatment of Hypovitaminosis D in Rheumatoid Arthritis

A NA study of Rheumatoid Arthritis and Hypovitaminosis D, sponsored by University of Wisconsin, Madison.

Completed
Registry status
NA
Development phase
22
Enrollment target
1
Study location

NCT00423358 is a NA study of Rheumatoid Arthritis and Hypovitaminosis D that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 22 participants, below the 4,691-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00423358, a NA study of Rheumatoid Arthritis and Hypovitaminosis D, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
NA
Development phase
22 participants
Enrollment target
1
Study location

Study Summary

This study recruits individuals with rheumatoid arthritis (RA) and low vitamin D concentrations. Subjects are dosed with vitamin D or placebo for one year. Primary outcome is change in bone turnover markers, additionally, bone mineral density and parameters of RA status are evaluated throughout the study.

Interventions

  • DIETARY_SUPPLEMENT Vitamin D
  • DIETARY_SUPPLEMENT placebo

Study Locations (1)

Wisconsin

  • University of Wisconsin - Madison

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2005-02
Est. Completion 2009-02
Phase NA

Sponsor

University of Wisconsin, Madison

1,039 total trials

What the Registry Record Tells You About NCT00423358

The ClinicalTrials.gov registry entry for NCT00423358 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,691-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (100% lower). The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 2 interventions - of which Vitamin D is the first listed.

NCT00423358 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT00423358 about?

NCT00423358 is a clinical study titled "Treatment of Hypovitaminosis D in Rheumatoid Arthritis". This study recruits individuals with rheumatoid arthritis (RA) and low vitamin D concentrations. Subjects are dosed with vitamin D or placebo for one year. Primary outcome is change in bone turnover markers, additionally, bone mineral density and parameters of RA status are evaluated throughout the ...

What is the current status of trial NCT00423358?

This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2005-02. Estimated completion is 2009-02.

What conditions does trial NCT00423358 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis, Hypovitaminosis D.

What interventions are being tested in trial NCT00423358?

The interventions under investigation include: Vitamin D (DIETARY_SUPPLEMENT), placebo (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT00423358?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00423358 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rheumatoid Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.